Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence (Q34646375)

3 August 2017

1 reference

title

Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence (English)

1 reference

cost-effectiveness analysis

3 August 2017

0 references

1 reference

0 references

1 reference

Lorna Guinness

4

0 references

author name string

Andrew Creese

series ordinal

1

1 reference

3 August 2017

Katherine Floyd

series ordinal

2

1 reference

3 August 2017

Anita Alban

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

359

1 reference

3 August 2017

9318

1 reference

3 August 2017

1635-1643

1 reference

Fighting global AIDS: the value of cost-effectiveness analysis

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries. Ghent International Working Group on Mother-to-Child Transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Benefits of HIV screening of blood transfusions in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

The cost of home-based care for HIV/AIDS patients in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Feasibility of hospital-based blood banking: a Tanzanian case study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

The real and the nominal? Making inflationary adjustments to cost and other economic data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

Public spending on health care: how are different criteria related?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908595-1

7 January 2021

10.1016/S0140-6736(02)08595-1

Identifiers

DOI

1 reference

release_reyyc6cig5drvh5fu2mhritdry

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/reyyc6cig5drvh5fu2mhritdry

24 November 2022

mapped directly with Wikidata item

1 reference